nodes	percent_of_prediction	percent_of_DWPC	metapath
Moxifloxacin—TOP2A—Etoposide—brain cancer	0.622	1	CbGbCtD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—S100A6—brain cancer	0.00812	0.201	CbGpPWpGaD
Moxifloxacin—TOP2A—Teniposide—Etoposide—brain cancer	0.00364	0.5	CbGdCrCtD
Moxifloxacin—TOP2A—Podofilox—Etoposide—brain cancer	0.00364	0.5	CbGdCrCtD
Moxifloxacin—TOP2A—G0 and Early G1—CCNE1—brain cancer	0.00204	0.0504	CbGpPWpGaD
Moxifloxacin—TOP2A—G0 and Early G1—PCNA—brain cancer	0.0018	0.0446	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 1—APC—brain cancer	0.0013	0.0323	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—brain cancer	0.00127	0.0314	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—HES1—brain cancer	0.0012	0.0297	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—NTRK3—brain cancer	0.00117	0.029	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—SKP2—brain cancer	0.00112	0.0277	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—DNMT1—brain cancer	0.00105	0.026	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK6—brain cancer	0.000997	0.0247	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—CTNNB1—brain cancer	0.00084	0.0208	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—SKP2—brain cancer	0.000787	0.0195	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	0.000751	0.0186	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—brain cancer	0.000719	0.0178	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDK6—brain cancer	0.000702	0.0174	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—MYC—brain cancer	0.00068	0.0168	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	0.000665	0.0165	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—EGFR—brain cancer	0.000665	0.0165	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—PPP1R12A—brain cancer	0.000636	0.0157	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000629	0.0156	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000596	0.0148	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	0.000575	0.0142	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—PPP1R12A—brain cancer	0.000569	0.0141	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—TP53—brain cancer	0.000559	0.0138	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CCNE1—brain cancer	0.000528	0.0131	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000503	0.0125	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—PCNA—brain cancer	0.000468	0.0116	CbGpPWpGaD
Moxifloxacin—Haemorrhage—Carmustine—brain cancer	0.000464	0.0014	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Hydroxyurea—brain cancer	0.000463	0.0014	CcSEcCtD
Moxifloxacin—Anaemia—Hydroxyurea—brain cancer	0.000461	0.0014	CcSEcCtD
Moxifloxacin—Hallucination—Carmustine—brain cancer	0.000461	0.0014	CcSEcCtD
Moxifloxacin—Hypoaesthesia—Carmustine—brain cancer	0.000461	0.0014	CcSEcCtD
Moxifloxacin—Decreased appetite—Procarbazine—brain cancer	0.000458	0.00139	CcSEcCtD
Moxifloxacin—Alanine aminotransferase increased—Etoposide—brain cancer	0.000457	0.00138	CcSEcCtD
Moxifloxacin—Oedema peripheral—Carmustine—brain cancer	0.000457	0.00138	CcSEcCtD
Moxifloxacin—Connective tissue disorder—Carmustine—brain cancer	0.000456	0.00138	CcSEcCtD
Moxifloxacin—Fatigue—Procarbazine—brain cancer	0.000454	0.00137	CcSEcCtD
Moxifloxacin—Haemoglobin—Temozolomide—brain cancer	0.00045	0.00136	CcSEcCtD
Moxifloxacin—Malaise—Hydroxyurea—brain cancer	0.00045	0.00136	CcSEcCtD
Moxifloxacin—Constipation—Procarbazine—brain cancer	0.00045	0.00136	CcSEcCtD
Moxifloxacin—Pain—Procarbazine—brain cancer	0.00045	0.00136	CcSEcCtD
Moxifloxacin—Hepatitis—Temozolomide—brain cancer	0.000448	0.00136	CcSEcCtD
Moxifloxacin—Haemorrhage—Temozolomide—brain cancer	0.000448	0.00136	CcSEcCtD
Moxifloxacin—Dysphagia—Etoposide—brain cancer	0.000448	0.00136	CcSEcCtD
Moxifloxacin—Leukopenia—Hydroxyurea—brain cancer	0.000447	0.00135	CcSEcCtD
Moxifloxacin—Visual impairment—Carmustine—brain cancer	0.000447	0.00135	CcSEcCtD
Moxifloxacin—Hypoaesthesia—Temozolomide—brain cancer	0.000446	0.00135	CcSEcCtD
Moxifloxacin—Hallucination—Temozolomide—brain cancer	0.000446	0.00135	CcSEcCtD
Moxifloxacin—Pharyngitis—Temozolomide—brain cancer	0.000445	0.00135	CcSEcCtD
Moxifloxacin—Urinary tract disorder—Temozolomide—brain cancer	0.000442	0.00134	CcSEcCtD
Moxifloxacin—Oedema peripheral—Temozolomide—brain cancer	0.000441	0.00134	CcSEcCtD
Moxifloxacin—Bronchospasm—Etoposide—brain cancer	0.000441	0.00133	CcSEcCtD
Moxifloxacin—Connective tissue disorder—Temozolomide—brain cancer	0.00044	0.00133	CcSEcCtD
Moxifloxacin—Urethral disorder—Temozolomide—brain cancer	0.000439	0.00133	CcSEcCtD
Moxifloxacin—Feeling abnormal—Procarbazine—brain cancer	0.000434	0.00131	CcSEcCtD
Moxifloxacin—Eye disorder—Carmustine—brain cancer	0.000433	0.00131	CcSEcCtD
Moxifloxacin—Convulsion—Hydroxyurea—brain cancer	0.000432	0.00131	CcSEcCtD
Moxifloxacin—Visual impairment—Temozolomide—brain cancer	0.000432	0.00131	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Procarbazine—brain cancer	0.00043	0.0013	CcSEcCtD
Moxifloxacin—Pancytopenia—Etoposide—brain cancer	0.000425	0.00129	CcSEcCtD
Moxifloxacin—Erythema multiforme—Temozolomide—brain cancer	0.000424	0.00128	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000422	0.00128	CcSEcCtD
Moxifloxacin—Discomfort—Hydroxyurea—brain cancer	0.00042	0.00127	CcSEcCtD
Moxifloxacin—Neutropenia—Etoposide—brain cancer	0.000419	0.00127	CcSEcCtD
Moxifloxacin—Eye disorder—Temozolomide—brain cancer	0.000419	0.00127	CcSEcCtD
Moxifloxacin—Urticaria—Procarbazine—brain cancer	0.000418	0.00127	CcSEcCtD
Moxifloxacin—Tinnitus—Temozolomide—brain cancer	0.000418	0.00126	CcSEcCtD
Moxifloxacin—Body temperature increased—Procarbazine—brain cancer	0.000416	0.00126	CcSEcCtD
Moxifloxacin—Abdominal pain—Procarbazine—brain cancer	0.000416	0.00126	CcSEcCtD
Moxifloxacin—Cardiac disorder—Temozolomide—brain cancer	0.000416	0.00126	CcSEcCtD
Moxifloxacin—Arrhythmia—Carmustine—brain cancer	0.000414	0.00125	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000413	0.0102	CbGpPWpGaD
Moxifloxacin—Oedema—Hydroxyurea—brain cancer	0.000407	0.00123	CcSEcCtD
Moxifloxacin—Angiopathy—Temozolomide—brain cancer	0.000406	0.00123	CcSEcCtD
Moxifloxacin—Mental disorder—Carmustine—brain cancer	0.000406	0.00123	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000405	0.01	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—brain cancer	0.000405	0.01	CbGpPWpGaD
Moxifloxacin—Immune system disorder—Temozolomide—brain cancer	0.000405	0.00123	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Temozolomide—brain cancer	0.000404	0.00122	CcSEcCtD
Moxifloxacin—Erythema—Carmustine—brain cancer	0.000404	0.00122	CcSEcCtD
Moxifloxacin—Malnutrition—Carmustine—brain cancer	0.000404	0.00122	CcSEcCtD
Moxifloxacin—Chills—Temozolomide—brain cancer	0.000402	0.00122	CcSEcCtD
Moxifloxacin—Pneumonia—Etoposide—brain cancer	0.000402	0.00122	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.0004	0.00991	CbGpPWpGaD
Moxifloxacin—Nervous system disorder—Hydroxyurea—brain cancer	0.0004	0.00121	CcSEcCtD
Moxifloxacin—Infestation—Etoposide—brain cancer	0.000399	0.00121	CcSEcCtD
Moxifloxacin—Infestation NOS—Etoposide—brain cancer	0.000399	0.00121	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Hydroxyurea—brain cancer	0.000399	0.00121	CcSEcCtD
Moxifloxacin—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000396	0.0012	CcSEcCtD
Moxifloxacin—Skin disorder—Hydroxyurea—brain cancer	0.000396	0.0012	CcSEcCtD
Moxifloxacin—Acute coronary syndrome—Etoposide—brain cancer	0.000394	0.00119	CcSEcCtD
Moxifloxacin—Renal failure—Etoposide—brain cancer	0.000393	0.00119	CcSEcCtD
Moxifloxacin—Mental disorder—Temozolomide—brain cancer	0.000392	0.00119	CcSEcCtD
Moxifloxacin—Neuropathy peripheral—Etoposide—brain cancer	0.000391	0.00119	CcSEcCtD
Moxifloxacin—Myocardial infarction—Etoposide—brain cancer	0.000391	0.00119	CcSEcCtD
Moxifloxacin—Back pain—Carmustine—brain cancer	0.00039	0.00118	CcSEcCtD
Moxifloxacin—Malnutrition—Temozolomide—brain cancer	0.00039	0.00118	CcSEcCtD
Moxifloxacin—Erythema—Temozolomide—brain cancer	0.00039	0.00118	CcSEcCtD
Moxifloxacin—Stomatitis—Etoposide—brain cancer	0.000389	0.00118	CcSEcCtD
Moxifloxacin—Jaundice—Etoposide—brain cancer	0.000389	0.00118	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—SIRT1—brain cancer	0.000389	0.00963	CbGpPWpGaD
Moxifloxacin—Anorexia—Hydroxyurea—brain cancer	0.000388	0.00118	CcSEcCtD
Moxifloxacin—Hypersensitivity—Procarbazine—brain cancer	0.000388	0.00117	CcSEcCtD
Moxifloxacin—Dysgeusia—Temozolomide—brain cancer	0.000382	0.00116	CcSEcCtD
Moxifloxacin—Vision blurred—Carmustine—brain cancer	0.00038	0.00115	CcSEcCtD
Moxifloxacin—Tremor—Carmustine—brain cancer	0.000378	0.00114	CcSEcCtD
Moxifloxacin—Asthenia—Procarbazine—brain cancer	0.000378	0.00114	CcSEcCtD
Moxifloxacin—Hepatobiliary disease—Etoposide—brain cancer	0.000378	0.00114	CcSEcCtD
Moxifloxacin—Back pain—Temozolomide—brain cancer	0.000377	0.00114	CcSEcCtD
Moxifloxacin—Anaemia—Carmustine—brain cancer	0.000373	0.00113	CcSEcCtD
Moxifloxacin—Agranulocytosis—Etoposide—brain cancer	0.000373	0.00113	CcSEcCtD
Moxifloxacin—Pruritus—Procarbazine—brain cancer	0.000372	0.00113	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000372	0.00921	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.000371	0.00919	CbGpPWpGaD
Moxifloxacin—Agitation—Carmustine—brain cancer	0.000371	0.00112	CcSEcCtD
Moxifloxacin—Vision blurred—Temozolomide—brain cancer	0.000368	0.00111	CcSEcCtD
Moxifloxacin—Tremor—Temozolomide—brain cancer	0.000365	0.00111	CcSEcCtD
Moxifloxacin—Dyspnoea—Hydroxyurea—brain cancer	0.000363	0.0011	CcSEcCtD
Moxifloxacin—Somnolence—Hydroxyurea—brain cancer	0.000362	0.0011	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Temozolomide—brain cancer	0.000362	0.0011	CcSEcCtD
Moxifloxacin—Leukopenia—Carmustine—brain cancer	0.000361	0.00109	CcSEcCtD
Moxifloxacin—Anaemia—Temozolomide—brain cancer	0.00036	0.00109	CcSEcCtD
Moxifloxacin—Diarrhoea—Procarbazine—brain cancer	0.00036	0.00109	CcSEcCtD
Moxifloxacin—Dyspepsia—Hydroxyurea—brain cancer	0.000359	0.00109	CcSEcCtD
Moxifloxacin—Agitation—Temozolomide—brain cancer	0.000358	0.00109	CcSEcCtD
Moxifloxacin—Hypoaesthesia—Etoposide—brain cancer	0.000357	0.00108	CcSEcCtD
Moxifloxacin—Angioedema—Temozolomide—brain cancer	0.000356	0.00108	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000355	0.00878	CbGpPWpGaD
Moxifloxacin—Decreased appetite—Hydroxyurea—brain cancer	0.000354	0.00107	CcSEcCtD
Moxifloxacin—Urinary tract disorder—Etoposide—brain cancer	0.000354	0.00107	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000352	0.00106	CcSEcCtD
Moxifloxacin—Malaise—Temozolomide—brain cancer	0.000352	0.00106	CcSEcCtD
Moxifloxacin—Urethral disorder—Etoposide—brain cancer	0.000351	0.00106	CcSEcCtD
Moxifloxacin—Fatigue—Hydroxyurea—brain cancer	0.000351	0.00106	CcSEcCtD
Moxifloxacin—Vertigo—Temozolomide—brain cancer	0.00035	0.00106	CcSEcCtD
Moxifloxacin—Convulsion—Carmustine—brain cancer	0.00035	0.00106	CcSEcCtD
Moxifloxacin—Leukopenia—Temozolomide—brain cancer	0.000349	0.00106	CcSEcCtD
Moxifloxacin—Hypertension—Carmustine—brain cancer	0.000348	0.00105	CcSEcCtD
Moxifloxacin—Pain—Hydroxyurea—brain cancer	0.000348	0.00105	CcSEcCtD
Moxifloxacin—Constipation—Hydroxyurea—brain cancer	0.000348	0.00105	CcSEcCtD
Moxifloxacin—Dizziness—Procarbazine—brain cancer	0.000348	0.00105	CcSEcCtD
Moxifloxacin—Palpitations—Temozolomide—brain cancer	0.000345	0.00104	CcSEcCtD
Moxifloxacin—Myalgia—Carmustine—brain cancer	0.000344	0.00104	CcSEcCtD
Moxifloxacin—Chest pain—Carmustine—brain cancer	0.000344	0.00104	CcSEcCtD
Moxifloxacin—Anxiety—Carmustine—brain cancer	0.000342	0.00104	CcSEcCtD
Moxifloxacin—Cough—Temozolomide—brain cancer	0.00034	0.00103	CcSEcCtD
Moxifloxacin—Erythema multiforme—Etoposide—brain cancer	0.000339	0.00103	CcSEcCtD
Moxifloxacin—Convulsion—Temozolomide—brain cancer	0.000338	0.00102	CcSEcCtD
Moxifloxacin—Hypertension—Temozolomide—brain cancer	0.000337	0.00102	CcSEcCtD
Moxifloxacin—Feeling abnormal—Hydroxyurea—brain cancer	0.000336	0.00102	CcSEcCtD
Moxifloxacin—Eye disorder—Etoposide—brain cancer	0.000335	0.00101	CcSEcCtD
Moxifloxacin—Vomiting—Procarbazine—brain cancer	0.000335	0.00101	CcSEcCtD
Moxifloxacin—Cardiac disorder—Etoposide—brain cancer	0.000333	0.00101	CcSEcCtD
Moxifloxacin—Confusional state—Carmustine—brain cancer	0.000332	0.00101	CcSEcCtD
Moxifloxacin—Arthralgia—Temozolomide—brain cancer	0.000332	0.00101	CcSEcCtD
Moxifloxacin—Myalgia—Temozolomide—brain cancer	0.000332	0.00101	CcSEcCtD
Moxifloxacin—Rash—Procarbazine—brain cancer	0.000332	0.001	CcSEcCtD
Moxifloxacin—Dermatitis—Procarbazine—brain cancer	0.000332	0.001	CcSEcCtD
Moxifloxacin—Anxiety—Temozolomide—brain cancer	0.000331	0.001	CcSEcCtD
Moxifloxacin—Headache—Procarbazine—brain cancer	0.00033	0.000998	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00033	0.000998	CcSEcCtD
Moxifloxacin—Oedema—Carmustine—brain cancer	0.000329	0.000997	CcSEcCtD
Moxifloxacin—Discomfort—Temozolomide—brain cancer	0.000328	0.000993	CcSEcCtD
Moxifloxacin—Angiopathy—Etoposide—brain cancer	0.000325	0.000985	CcSEcCtD
Moxifloxacin—Dry mouth—Temozolomide—brain cancer	0.000325	0.000983	CcSEcCtD
Moxifloxacin—Immune system disorder—Etoposide—brain cancer	0.000324	0.00098	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Etoposide—brain cancer	0.000323	0.000978	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Carmustine—brain cancer	0.000322	0.000976	CcSEcCtD
Moxifloxacin—Body temperature increased—Hydroxyurea—brain cancer	0.000322	0.000975	CcSEcCtD
Moxifloxacin—Chills—Etoposide—brain cancer	0.000322	0.000974	CcSEcCtD
Moxifloxacin—Tachycardia—Carmustine—brain cancer	0.000321	0.000973	CcSEcCtD
Moxifloxacin—Confusional state—Temozolomide—brain cancer	0.000321	0.000972	CcSEcCtD
Moxifloxacin—Oedema—Temozolomide—brain cancer	0.000318	0.000964	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Temozolomide—brain cancer	0.000318	0.000964	CcSEcCtD
Moxifloxacin—Anorexia—Carmustine—brain cancer	0.000314	0.00095	CcSEcCtD
Moxifloxacin—Nausea—Procarbazine—brain cancer	0.000313	0.000947	CcSEcCtD
Moxifloxacin—Nervous system disorder—Temozolomide—brain cancer	0.000312	0.000945	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Temozolomide—brain cancer	0.000312	0.000943	CcSEcCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—brain cancer	0.000309	0.00765	CbGpPWpGaD
Moxifloxacin—Skin disorder—Temozolomide—brain cancer	0.000309	0.000936	CcSEcCtD
Moxifloxacin—Hypotension—Carmustine—brain cancer	0.000308	0.000932	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Temozolomide—brain cancer	0.000308	0.000932	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000307	0.00759	CbGpPWpGaD
Moxifloxacin—Dysgeusia—Etoposide—brain cancer	0.000306	0.000925	CcSEcCtD
Moxifloxacin—Anorexia—Temozolomide—brain cancer	0.000303	0.000919	CcSEcCtD
Moxifloxacin—Back pain—Etoposide—brain cancer	0.000302	0.000914	CcSEcCtD
Moxifloxacin—Hypersensitivity—Hydroxyurea—brain cancer	0.0003	0.000909	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Carmustine—brain cancer	0.0003	0.000908	CcSEcCtD
Moxifloxacin—Muscle spasms—Etoposide—brain cancer	0.0003	0.000908	CcSEcCtD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.000298	0.00737	CbGpPWpGaD
Moxifloxacin—Insomnia—Carmustine—brain cancer	0.000298	0.000902	CcSEcCtD
Moxifloxacin—Paraesthesia—Carmustine—brain cancer	0.000296	0.000895	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—CDK4—brain cancer	0.000294	0.00728	CbGpPWpGaD
Moxifloxacin—Dyspnoea—Carmustine—brain cancer	0.000294	0.000889	CcSEcCtD
Moxifloxacin—Somnolence—Carmustine—brain cancer	0.000293	0.000886	CcSEcCtD
Moxifloxacin—Asthenia—Hydroxyurea—brain cancer	0.000292	0.000885	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00029	0.000878	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Etoposide—brain cancer	0.00029	0.000877	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—SKP2—brain cancer	0.000289	0.00714	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000289	0.00714	CbGpPWpGaD
Moxifloxacin—Anaemia—Etoposide—brain cancer	0.000288	0.000873	CcSEcCtD
Moxifloxacin—Insomnia—Temozolomide—brain cancer	0.000288	0.000872	CcSEcCtD
Moxifloxacin—Decreased appetite—Carmustine—brain cancer	0.000286	0.000867	CcSEcCtD
Moxifloxacin—Paraesthesia—Temozolomide—brain cancer	0.000286	0.000865	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Carmustine—brain cancer	0.000284	0.000861	CcSEcCtD
Moxifloxacin—Dyspnoea—Temozolomide—brain cancer	0.000284	0.000859	CcSEcCtD
Moxifloxacin—Somnolence—Temozolomide—brain cancer	0.000283	0.000857	CcSEcCtD
Moxifloxacin—Pain—Carmustine—brain cancer	0.000282	0.000853	CcSEcCtD
Moxifloxacin—Constipation—Carmustine—brain cancer	0.000282	0.000853	CcSEcCtD
Moxifloxacin—Malaise—Etoposide—brain cancer	0.000281	0.000852	CcSEcCtD
Moxifloxacin—Vertigo—Etoposide—brain cancer	0.00028	0.000849	CcSEcCtD
Moxifloxacin—Dyspepsia—Temozolomide—brain cancer	0.00028	0.000848	CcSEcCtD
Moxifloxacin—Leukopenia—Etoposide—brain cancer	0.000279	0.000846	CcSEcCtD
Moxifloxacin—Diarrhoea—Hydroxyurea—brain cancer	0.000279	0.000844	CcSEcCtD
Moxifloxacin—Decreased appetite—Temozolomide—brain cancer	0.000277	0.000838	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Temozolomide—brain cancer	0.000275	0.000832	CcSEcCtD
Moxifloxacin—Fatigue—Temozolomide—brain cancer	0.000274	0.000831	CcSEcCtD
Moxifloxacin—Loss of consciousness—Etoposide—brain cancer	0.000274	0.00083	CcSEcCtD
Moxifloxacin—Cough—Etoposide—brain cancer	0.000272	0.000824	CcSEcCtD
Moxifloxacin—Constipation—Temozolomide—brain cancer	0.000272	0.000824	CcSEcCtD
Moxifloxacin—Pain—Temozolomide—brain cancer	0.000272	0.000824	CcSEcCtD
Moxifloxacin—Feeling abnormal—Carmustine—brain cancer	0.000271	0.000822	CcSEcCtD
Moxifloxacin—Convulsion—Etoposide—brain cancer	0.00027	0.000819	CcSEcCtD
Moxifloxacin—Hypertension—Etoposide—brain cancer	0.000269	0.000816	CcSEcCtD
Moxifloxacin—Dizziness—Hydroxyurea—brain cancer	0.000269	0.000816	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Carmustine—brain cancer	0.000269	0.000815	CcSEcCtD
Moxifloxacin—Chest pain—Etoposide—brain cancer	0.000266	0.000804	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000264	0.000799	CcSEcCtD
Moxifloxacin—Discomfort—Etoposide—brain cancer	0.000262	0.000795	CcSEcCtD
Moxifloxacin—Feeling abnormal—Temozolomide—brain cancer	0.000262	0.000794	CcSEcCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—brain cancer	0.000261	0.00647	CbGpPWpGaD
Moxifloxacin—Abdominal pain—Carmustine—brain cancer	0.00026	0.000788	CcSEcCtD
Moxifloxacin—Body temperature increased—Carmustine—brain cancer	0.00026	0.000788	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Temozolomide—brain cancer	0.00026	0.000788	CcSEcCtD
Moxifloxacin—Vomiting—Hydroxyurea—brain cancer	0.000259	0.000784	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—SKP2—brain cancer	0.000258	0.00639	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDK6—brain cancer	0.000257	0.00637	CbGpPWpGaD
Moxifloxacin—Rash—Hydroxyurea—brain cancer	0.000257	0.000778	CcSEcCtD
Moxifloxacin—Confusional state—Etoposide—brain cancer	0.000257	0.000777	CcSEcCtD
Moxifloxacin—Dermatitis—Hydroxyurea—brain cancer	0.000257	0.000777	CcSEcCtD
Moxifloxacin—Headache—Hydroxyurea—brain cancer	0.000255	0.000773	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Etoposide—brain cancer	0.000255	0.000771	CcSEcCtD
Moxifloxacin—Urticaria—Temozolomide—brain cancer	0.000253	0.000766	CcSEcCtD
Moxifloxacin—Abdominal pain—Temozolomide—brain cancer	0.000252	0.000762	CcSEcCtD
Moxifloxacin—Body temperature increased—Temozolomide—brain cancer	0.000252	0.000762	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Etoposide—brain cancer	0.000249	0.000755	CcSEcCtD
Moxifloxacin—Tachycardia—Etoposide—brain cancer	0.000249	0.000753	CcSEcCtD
Moxifloxacin—Skin disorder—Etoposide—brain cancer	0.000247	0.000749	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Etoposide—brain cancer	0.000246	0.000745	CcSEcCtD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—brain cancer	0.000245	0.00605	CbGpPWpGaD
Moxifloxacin—Anorexia—Etoposide—brain cancer	0.000243	0.000735	CcSEcCtD
Moxifloxacin—Hypersensitivity—Carmustine—brain cancer	0.000243	0.000735	CcSEcCtD
Moxifloxacin—Nausea—Hydroxyurea—brain cancer	0.000242	0.000733	CcSEcCtD
Moxifloxacin—Hypotension—Etoposide—brain cancer	0.000238	0.000721	CcSEcCtD
Moxifloxacin—Asthenia—Carmustine—brain cancer	0.000236	0.000715	CcSEcCtD
Moxifloxacin—Hypersensitivity—Temozolomide—brain cancer	0.000234	0.00071	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—CDK6—brain cancer	0.00023	0.00569	CbGpPWpGaD
Moxifloxacin—Paraesthesia—Etoposide—brain cancer	0.000229	0.000692	CcSEcCtD
Moxifloxacin—Asthenia—Temozolomide—brain cancer	0.000228	0.000691	CcSEcCtD
Moxifloxacin—Dyspnoea—Etoposide—brain cancer	0.000227	0.000687	CcSEcCtD
Moxifloxacin—Somnolence—Etoposide—brain cancer	0.000226	0.000685	CcSEcCtD
Moxifloxacin—Diarrhoea—Carmustine—brain cancer	0.000225	0.000682	CcSEcCtD
Moxifloxacin—Pruritus—Temozolomide—brain cancer	0.000225	0.000682	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000224	0.00554	CbGpPWpGaD
Moxifloxacin—Decreased appetite—Etoposide—brain cancer	0.000221	0.00067	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Etoposide—brain cancer	0.00022	0.000666	CcSEcCtD
Moxifloxacin—Fatigue—Etoposide—brain cancer	0.00022	0.000665	CcSEcCtD
Moxifloxacin—Dizziness—Carmustine—brain cancer	0.000218	0.000659	CcSEcCtD
Moxifloxacin—Pain—Etoposide—brain cancer	0.000218	0.000659	CcSEcCtD
Moxifloxacin—Constipation—Etoposide—brain cancer	0.000218	0.000659	CcSEcCtD
Moxifloxacin—Diarrhoea—Temozolomide—brain cancer	0.000218	0.000659	CcSEcCtD
Moxifloxacin—Dizziness—Temozolomide—brain cancer	0.00021	0.000637	CcSEcCtD
Moxifloxacin—Feeling abnormal—Etoposide—brain cancer	0.00021	0.000635	CcSEcCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—brain cancer	0.00021	0.00519	CbGpPWpGaD
Moxifloxacin—Vomiting—Carmustine—brain cancer	0.000209	0.000634	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Etoposide—brain cancer	0.000208	0.000631	CcSEcCtD
Moxifloxacin—Rash—Carmustine—brain cancer	0.000208	0.000629	CcSEcCtD
Moxifloxacin—Dermatitis—Carmustine—brain cancer	0.000207	0.000628	CcSEcCtD
Moxifloxacin—Headache—Carmustine—brain cancer	0.000206	0.000625	CcSEcCtD
Moxifloxacin—Vomiting—Temozolomide—brain cancer	0.000202	0.000613	CcSEcCtD
Moxifloxacin—Urticaria—Etoposide—brain cancer	0.000202	0.000613	CcSEcCtD
Moxifloxacin—Abdominal pain—Etoposide—brain cancer	0.000201	0.00061	CcSEcCtD
Moxifloxacin—Body temperature increased—Etoposide—brain cancer	0.000201	0.00061	CcSEcCtD
Moxifloxacin—Rash—Temozolomide—brain cancer	0.000201	0.000608	CcSEcCtD
Moxifloxacin—Dermatitis—Temozolomide—brain cancer	0.0002	0.000607	CcSEcCtD
Moxifloxacin—Headache—Temozolomide—brain cancer	0.000199	0.000604	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000198	0.0049	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000196	0.00485	CbGpPWpGaD
Moxifloxacin—Nausea—Carmustine—brain cancer	0.000196	0.000592	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CCNE1—brain cancer	0.000194	0.0048	CbGpPWpGaD
Moxifloxacin—Nausea—Temozolomide—brain cancer	0.000189	0.000572	CcSEcCtD
Moxifloxacin—Hypersensitivity—Etoposide—brain cancer	0.000188	0.000568	CcSEcCtD
Moxifloxacin—Asthenia—Etoposide—brain cancer	0.000183	0.000553	CcSEcCtD
Moxifloxacin—Pruritus—Etoposide—brain cancer	0.00018	0.000546	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—BRCA2—brain cancer	0.000179	0.00443	CbGpPWpGaD
Moxifloxacin—Diarrhoea—Etoposide—brain cancer	0.000174	0.000528	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—CCNE1—brain cancer	0.000173	0.00429	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000173	0.00427	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—PCNA—brain cancer	0.000172	0.00425	CbGpPWpGaD
Moxifloxacin—Dizziness—Etoposide—brain cancer	0.000168	0.00051	CcSEcCtD
Moxifloxacin—Vomiting—Etoposide—brain cancer	0.000162	0.00049	CcSEcCtD
Moxifloxacin—Rash—Etoposide—brain cancer	0.000161	0.000486	CcSEcCtD
Moxifloxacin—Dermatitis—Etoposide—brain cancer	0.00016	0.000486	CcSEcCtD
Moxifloxacin—Headache—Etoposide—brain cancer	0.00016	0.000483	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000159	0.00393	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000155	0.00384	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—PCNA—brain cancer	0.000154	0.0038	CbGpPWpGaD
Moxifloxacin—Nausea—Etoposide—brain cancer	0.000151	0.000458	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—brain cancer	0.000148	0.00367	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDK4—brain cancer	0.000133	0.00328	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.00013	0.00323	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—TP53—brain cancer	0.000125	0.0031	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—brain cancer	0.000113	0.00281	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDKN2A—brain cancer	0.000101	0.00251	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—brain cancer	9.58e-05	0.00237	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CCND1—brain cancer	8.57e-05	0.00212	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—MYC—brain cancer	7.69e-05	0.0019	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MYC—brain cancer	6.87e-05	0.0017	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—TP53—brain cancer	5.64e-05	0.0014	CbGpPWpGaD
